Search
News & Events
Prospective Student EveningStudents met ORIGINS team at the recent Prospective Student Evening at Telethon Kids Institute.
Philanthropically-minded members of the community are lending their support to The Kids Research Institute Australia’s up-and-comers.
Bright Blue The Police Commissioner's Fund for Sick Kids has generously outfitted the The Kids brain tumour lab with a cancer analysis suite.
Find information on each session, and your pre-appointment checklist to ensure you are prepared.
Find answers to frequently asked questions about ORIGINS.
Understanding children and families' hospital experiences to reduce stress and support wellbeing
Research
Language in Little Ones (LiLO)The Language in Little Ones (LiLO) study is a five-year longitudinal study (2017-2021), funded through the National Health and Medical Research Council. The study investigates the quantity and quality of language exposure in the home environment during the first five years of a child’s life.
Research
Islet autoimmunity in young First Nations women with prediabetes and type 2 diabetesType 1 diabetes in First Nations peoples is low yet type 2 diabetes is at epidemic proportions. This study aimed to determine the prevalence of islet autoimmunity in First Nations women with dysglycaemia and its association with clinical features.
Research
Perceived stigma and self-stigma in young people at ultra-high risk for psychosis: Associations with identity-related, psychological and functional outcomesPerceived stigma and self-stigma negatively affect identity-related, psychological and functional outcomes among stigmatised populations. There is limited research exploring the impact of stigma among young people at ultra-high risk (UHR) for psychosis. We investigated the association of perceived stigma and self-stigma with these outcomes in young people at UHR.
Research
Scoping review of variation in clinical guidelines for delivery of injectable long-acting penicillin across Australia and Aotearoa New ZealandThis scoping review explores existing clinical guidelines on administration of benzathine benzylpenicillin (Bicillin L-A, Pfizer Australia) in Australia and Aotearoa New Zealand. The objective is to understand existing delivery guidance to address variation in care and cultural safety considerations, to support messaging during periods of stockout and to inform planning for new administration techniques.